Fluticasone propionate salmeterol

Results: 45



#Item
31Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended  Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani

Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2011-01-05 07:16:25
32Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended  Seretide

Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2013-06-20 11:23:14
33GLAXOSMITHKLINE  Sponsor Briefing Information ADVAIR DISKUS® (fluticasone propionate/salmeterol inhalation powder[removed]mcg, [removed]mcg and[removed]mcg

GLAXOSMITHKLINE Sponsor Briefing Information ADVAIR DISKUS® (fluticasone propionate/salmeterol inhalation powder[removed]mcg, [removed]mcg and[removed]mcg

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2008-12-05 08:30:11
34DOCUMENT INFORMATION PAGE

DOCUMENT INFORMATION PAGE

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 16:05:30
35

PDF Document

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-05 14:23:33
361 2 3 MEDICATION GUIDE ADVAIR HFA [ad′ vair[removed]Inhalation Aerosol

1 2 3 MEDICATION GUIDE ADVAIR HFA [ad′ vair[removed]Inhalation Aerosol

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-01-05 14:23:33
37DIVISION OF BIOEQUIVALENCE REVIEW

DIVISION OF BIOEQUIVALENCE REVIEW

Add to Reading List

Source URL: www.fda.gov

Language: English
38DOCUMENT INFORMATION PAGE

DOCUMENT INFORMATION PAGE

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 16:06:05
39IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398

IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398

Add to Reading List

Source URL: www.fda.gov

Language: English
40

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English